Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Outside the Lab Profession, Laboratory management, Regulation and standards

Surviving the PAMA Pinch

At a Glance

  • Rising healthcare costs in the USA are negatively affecting the overall growth of the country’s economy
  • In response to this challenge, the US Congress enacted the Protecting Access to Medicare Act (PAMA), which revises Medicare’s payment methodology for clinical laboratory tests
  • Payment cutbacks will affect clinical laboratories’ ability to maintain adequate profit margins
  • There are strategies, including product focus, laboratory test development, referencing out tests, and partnering with other labs, that can minimize PAMA’s effects
The PAMA problem

Healthcare costs are skyrocketing in the USA, surpassing US$3.4 trillion and totaling more than $10,000 per person in 2016 (1). With a growing number of aging Americans and an increase in life expectancy, these costs are expected to rise by approximately 5 percent per year over the next decade. If left unchecked, healthcare costs may top 25 percent of gross domestic product by 2025 – with a clear negative effect on the overall growth of the US economy.

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!

Login

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

About the Author

Eitan Akirav and Dieter Schapfel

Eiter Akirav is a Senior Manager of Business Development at Enzo, and an Assistant Professor at Stony Brook University, Farmingdale, USA.
Dieter Schapfel is Chief Medical Director at Enzo Clinical Labs, Enzo Biochem Inc., Farmingdale, USA.

Most Popular

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register